Herberman Rb

发表

Effects of biological response modifiers on effector cells with cytotoxic activity against tumors.

Herberman Rb, 1986 .

Summary: potential of interleukin-2 for the therapy of cancer.

Herberman Rb, 1984 .

Multiple functions of natural killer cells, including immunoregulation as well as resistance to tumor growth.

Herberman Rb, 1985 .

Extravasation of antitumor effector cells.

Whiteside Tl, Herberman Rb, 1992 .

Natural killer cells and their possible relevance to transplantation biology.

Herberman Rb, 1982 .

Natural killer (NK) cells and their possible roles in resistance against disease.

Herberman Rb, 1981 .

Humoral host defense mechanisms against tumors.

Herberman Rb, Ting Cc, 1976 .

DETECTION OF CELL-MEDIATED IMMUNITY AGAINST TUMOR-ASSOCIATED ANTIGENS OF HUMAN BREAST CARCINOMA BY MIGRATION INHIBITION AND LYMPHOCYTE-STIMULATION ASSAYS

R. Oldham, J. Dean, G. Cannon, 1976 .

Cell-mediated cytotoxicity against human tumors: lessons learned and future prospects.

Oldham Rk, Herberman Rb, 1983, Journal of biological response modifiers.

Design of clinical trials with biological response modifiers.

Herberman Rb, 1985 .

Natural killer cells and their possible roles in host resistance against tumors.

Herberman Rb, 1984 .

Adoptive therapy with purified CD8 cells in HIV infection.

Herberman Rb, 1992 .

Second counterpoint: animal tumor models and their relevance to human tumor immunology.

Herberman Rb, 1983 .

Biological response modifiers for the therapy of cancer.

Herberman Rb, 1985 .

51 Chromium-release assay for cell-mediated cytotoxicity of human leukemia and lymphoid tissue-culture cells.

P. Levine, R. Herberman, E. Rosenberg, 1973, National Cancer Institute monograph.